Beside luminal B BC, high expression of ZNF703 was also found by immunohistochemistry in a third of TNBC patients [42] as well as in other cancers such as gastric, colorectal, head and neck cancers, non-small cell lung, cholangiocarcinoma, papillary thyroid carcinoma (PTC), medullary thyroid carcinoma (MTC), hepatocellular carcinoma (HCC) and ovarian cancer [43,44,45,46,47,48,49,50,51]. Here, ZNF703 is linked to thyroid gland papillary carcinoma.